Wedica

Wedica is a medical technology company focused on the prevention of surgical site infections (SSIs), a major cause of post-operative morbidity and healthcare costs. The company is developing a proprietary platform designed to provide continuous, targeted antimicrobial protection at the incision site throughout the critical healing period. Founded by Dr. Michael J. Coady, a cardiac surgeon, Wedica's approach addresses the limitations of current standard-of-care infection prevention methods. The technology aims to significantly reduce the risk of infection in high-risk surgical procedures, such as cardiac and orthopedic surgeries. By improving patient safety and reducing hospital readmissions, Wedica seeks to provide value to both patients and healthcare providers.